期刊文献+

舌癌血清标记物的蛋白质组学研究 被引量:1

Proteomics study of the serum biomarkers in tongue cancer
原文传递
导出
摘要 目的通过运用蛋白质组学技术寻找舌癌血清特异性标记物,为舌癌早期诊断、病程监测以及预后判断提供可靠的血清学指标。方法采用舌癌 Tca8113细胞系体外培养,并移植于裸鼠。以正常裸鼠血清为对照,采用双向凝胶电泳分离技术分析荷瘤小鼠的血清蛋白表达谱,并通过质谱鉴定差异表达蛋白。结果在荷瘤裸鼠血清中分离和鉴定了5个差异表达蛋白,其中鳞状细胞癌抗原1检索得分最高,为97分,定量分析中变化最大,并与舌癌密切相关。结论荷瘤裸鼠血清中鳞状细胞癌抗原1高表达,有望成为舌癌的特异性血清标记物之一。 Objective To search for specific serum biomarkers associated with tongue cancer by means of the serum proteomics technology. Methods The tongue cancer ceils of human tongue cancer cell line Tca8113 were subcutaneously inoculated into nude mice, while control nude mice were injected with phosphate-buffered saline. Serums from these two group of mice were collected for proteomic analysis using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS). Results Comparing the serum 2-DE maps from the tumor-bearing mice with those produced from control mice, we found that squamous cell carcinoma antigen 1 was over expressed only in the serum of tumor-bearing mice. Conclusions The squamous cell carcinoma antigen 1 may be of great potential as the biomarker of tongue cancer and as the potential therapeutic target for gene therapy.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2007年第9期550-552,共3页 Chinese Journal of Stomatology
基金 国家自然科学基金(30500565) 中国博士后科学基金(2003034419)
关键词 舌肿瘤 鳞状细胞 生物学标记 Tongue neoplasms Carcinoma, squamous cell Biological markers
  • 相关文献

参考文献10

  • 1Christopher H, Rassekh, Jonas T, et al. Circulating markers in squamous cell carcinoma of the head and neck: a review. European J Cancer, Part B: Oral Oncology, 1994,30 (1) :23-28.
  • 2Uemura Y, Pak SC, Luke C, et al. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. Int J Cancer , 2000,89 (4) : 368-377.
  • 3Abraham JA, Mergia A, Whang JL, et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science, 1986, 233(4763) : 545-548.
  • 4Coombes KR, Morris JS, Hu J, et al. Serum proteomics profiling: a young technology begins to mature. Nat Biotechnol, 2005, 23 (3) : 291-292.
  • 5Fujii K, Nakano T, Kawamura T, et al. Multidimensional protein profiling technology and its application to human plasma proteome. J Proteome Res, 2004, 3(4) : 712-718.
  • 6Ornstein DK, Rayford W, Fusaro VA, et al. Serum proteomicprofiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol, 2004, 172(4 Pt 1 ) : 1302-1305.
  • 7Brichory F, Beer D, Le Naour F, et al. Proteomics-based identification of protein gene product 9. 5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res, 2001,61 (21) : 7908-7912.
  • 8Le Naour F, Misek DE, Krause MC, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res, 2001, 7( 11 ) : 3328-3335.
  • 9Klade CS, Voss T, Krystek E, et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics, 2001,1 ( 7 ) : 890-898.
  • 10Alaiya AA, Franzen B, Auer G, et al. Cancer proteomics : from identification of noval markers to creation of artificial learning models for tumor classification. Electrophoresis, 2000, 21 ( 6 ) : 1210-1217.

同被引文献13

  • 1李航,高岩.基底膜区结构蛋白在口腔癌及癌前病变方面的研究概况[J].北京口腔医学,2006,14(4):294-296. 被引量:1
  • 2Epstein JB,Sciubba J,Silverman S,et al.Utility of toluidine blue in oral premalignant lesion and squamous cell carcinoma:continuing research and implications for clinical practice[J].Head Neck,2007,29(10):948-958.
  • 3Lingen MW,Kalmar JR,Karrison T,et al.Critical evaluation of diagnostic aids for the detection of oral cancer[J].Oral Oncol,2008,44(1):10-22.
  • 4Barnes L,Evason JW,Reichart P,et al.头颈部肿瘤病理学和遗传学[M].刘红刚,高岩,译.北京:人民卫生出版社,2006:207-209.
  • 5Mehrotra R,Gupta A,Singh M,et al.Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions[J].Mol Cancer,2006,5:11.
  • 6Bhoopathi V,Kabani S,Mascarenhas AK.Low positive predictive value of the oral brush biopsy in detecting dysplastic oral lesions[J].Cancer,2009,115(5):1036-1040.
  • 7Pitiyage G,Tilakaratne WM,Tavassoli M,et al.Molecular markers in oral epthelial dysplasia:Review[J].J Oral Pathol Med,2009,38(10):737-752.
  • 8Maraki D,Becker J,Boecking A.Cytologic and DNA-cytometric very early diagnosis of oral cancer[J].J Oral Pathol Med,2004,33(7):398-404.
  • 9Remmerbach TW,Weidenbach H,Hemprich A,et al.Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry:report on four cases[J].Anal Cell Pathol.,2003,25(4):159-166.
  • 10Hu S,Arellano M,Boontheung P,et al.Salivary proteomics for oral cancer biomarker discovery[J].Clin Cancer Res,2008,14(19):6246-6252.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部